Bipolar Androgen Therapy in Men With Metastatic Castration-Resistant Prostate Cancer After Progression on Enzalutamide
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Bipolar Androgen Therapy in Men With Metastatic Castration-Resistant Prostate Cancer After Progression on Enzalutamide: An Open-Label, Phase 2, Multicohort Study
Lancet Oncol 2017 Dec 13;[EPub Ahead of Print], BA Teply, H Wang, B Luber, R Sullivan, I Rifkind, A Bruns, A Spitz, M DeCarli, V Sinibaldi, CF Pratz, C Lu, JL Silberstein, J Luo, MT Schweizer, CG Drake, MA Carducci, CJ Paller, ES Antonarakis, MA Eisenberger, SR DenmeadeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.